Search Results 151-160 of 17291 for Proto-oncogene
The Cancer Cell Genomics, Signaling and Metastasis Research Program of Mayo Clinic Comprehensive Cancer Center conducts research on the cellular genome, ...
Mayo Clinic specialists offer advanced care for young people with colorectal, appendiceal, pancreatic, gastric, bile duct or other GI cancers.
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Diagnosis during dose expansion (Part 2) – All patients (with the exception of patients with MTC enroled in Groups 3, 4 and 9) must have an oncogenic RET ...
The Copland Cancer Biology and Translational Research Lab at Mayo Clinic has created novel SCD1-specific inhibitors that are being developed for cancer ...
Resources. Dr. Kannan recommends exploring these professional and patient resources related to stem cells, cancer biology and breast cancer.
The goal of this study is to define the best testing practices in cancer genetics using new available technologies. Participation eligibility. Participant ...
View all · Ablation therapy · Capsule endoscopy · Chemotherapy · Colon cancer surgery · Colonoscopy · Comprehensive genomic profiling · CT enterography · CT scan ...
This phase I trial studies the side effects and the best dose of pazopanib hydrochloride in treating patients with solid tumors that has spread to other places ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.